Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.
Nature Communications
Havugimana, Pierre C PC; Goel, Raghuveera Kumar RK; Phanse, Sadhna S; Youssef, Ahmed A; Padhorny, Dzmitry D; Kotelnikov, Sergei S; Kozakov, Dima D; Emili, Andrew A
Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma.
Integrated genomics point to immune vulnerabilities in pleural mesothelioma.
Scientific Reports
Nastase, Anca A; Mandal, Amit A; Lu, Shir Kiong SK; Anbunathan, Hima H; Morris-Rosendahl, Deborah D; Zhang, Yu Zhi YZ; Sun, Xiao-Ming XM; Gennatas, Spyridon S; Rintoul, Robert C RC; Edwards, Matthew M; Bowman, Alex A; Chernova, Tatyana T; Benepal, Tim T; Lim, Eric E; Taylor, Anthony Newman AN; Nicholson, Andrew G AG; Popat, Sanjay S; Willis, Anne E AE; MacFarlane, Marion M; Lathrop, Mark M; Bowcock, Anne M AM; Moffatt, Miriam F MF; Cookson, William O C M WOCM
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
Annals Of Internal Medicine
Daar, Eric S ES; Tierney, Camlin C; Fischl, Margaret A MA; Sax, Paul E PE; Mollan, Katie K; Budhathoki, Chakra C; Godfrey, Catherine C; Jahed, Nasreen C NC; Myers, Laurie L; Katzenstein, David D; Farajallah, Awny A; Rooney, James F JF; Pappa, Keith A KA; Woodward, William C WC; Patterson, Kristine K; Bolivar, Hector H; Benson, Constance A CA; Collier, Ann C AC; ,
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen.
Hiv Clinical Trials
Hammer, Scott M SM; Ribaudo, Heather H; Bassett, Roland R; Mellors, John W JW; Demeter, Lisa M LM; Coombs, Robert W RW; Currier, Judith J; Morse, Gene D GD; Gerber, John G JG; Martinez, Ana I AI; Spreen, William W; Fischl, Margaret A MA; Squires, Kathleen E KE; ,
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.
The New England Journal Of Medicine
Sax, Paul E PE; Tierney, Camlin C; Collier, Ann C AC; Fischl, Margaret A MA; Mollan, Katie K; Peeples, Lynne L; Godfrey, Catherine C; Jahed, Nasreen C NC; Myers, Laurie L; Katzenstein, David D; Farajallah, Awny A; Rooney, James F JF; Ha, Belinda B; Woodward, William C WC; Koletar, Susan L SL; Johnson, Victoria A VA; Geiseler, P Jan PJ; Daar, Eric S ES; ,
Activities of atazanavir (BMS-232632) against a large panel of human immunodeficiency virus type 1 clinical isolates resistant to one or more approved protease inhibitors.
Antimicrobial Agents And Chemotherapy
Colonno, Richard J RJ; Thiry, Alexandra A; Limoli, Kay K; Parkin, Neil N